Briacell Therapeutics Corp (BCTX) Stock Price, Quote & News

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 921 1810

Fax: 604 921 1898

Website: briacell.com

Address:

Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

BHWinehouse May. 13 at 7:16 PM

$BCTX

0 · Reply

MoeMaze May. 13 at 7:03 PM

$BCTX what’s the use of all these news if the stock is stuck where it is !!!

0 · Reply

MikeTechnician May. 13 at 6:35 PM

$BCTX BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study https://www.globenewswire.com/news-release/2026/05/13/3293887/0/en/briacell-adds-penn-medicine-s-abramson-cancer-center-as-clinical-site-in-pivotal-phase-3-breast-cancer-study.html

0 · Reply

MikeTechnician May. 13 at 3:03 PM

Top-tier cancer centers continue aligning with innovative immunotherapy trials. $BCTX adds Penn’s Abramson Cancer Center to its pivotal Phase 3 study—highlighting growing institutional interest in next-gen breast cancer treatments. NEWS: https://bit.ly/3PCPxxi #oncology

0 · Reply

MikeTechnician May. 13 at 12:41 PM

$BCTX continues to strengthen its Phase 3 footprint: • Adds PENN’s Abramson Cancer Center • Expanding access to Bria-IMT + CPI regimen • Focus: advanced metastatic breast cancer • Primary endpoint: overall survival https://bit.ly/3PCPxxi #biotech #oncology #breastcancer

0 · Reply

SmallCapVoice May. 13 at 11:34 AM

$BCTX continues to expand the reach of its pivotal Phase 3 breast cancer study with the addition of Penn Medicine’s Abramson Cancer Center as a clinical site. A world-renowned cancer center joining the Bria-ABC study adds another major name to BriaCell’s growing network as enrollment momentum continues. https://www.globenewswire.com/news-release/2026/05/13/3293887/0/en/briacell-adds-penn-medicine-s-abramson-cancer-center-as-clinical-site-in-pivotal-phase-3-breast-cancer-study.html

0 · Reply

JediGreen May. 13 at 5:16 AM

$BCTX https://youtube.com/shorts/fCRak6pv6Tk?si=CL1QtykXz3-k0es6

0 · Reply

JediGreen May. 13 at 4:59 AM

$BCTX https://finance.yahoo.com/sectors/healthcare/articles/briacell-announces-six-clinical-data-113000237.html

0 · Reply

Rohtan May. 12 at 10:55 PM

$BCTX

0 · Reply

SmallCapGrowth May. 12 at 6:57 PM

$BCTX

1 · Reply

BriaCell adds Penn Medicine as Phase 3 breast cancer study site

Wed, 13 May 2026 07:30:00 -0400 - 8 hours ago

BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Tue, 12 May 2026 07:30:00 -0400 - 1 day ago

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Thu, 07 May 2026 07:30:00 -0400 - 6 days ago

BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

2026-05-07T04:03:56.000Z - 6 days ago

BriaCell receives FDA clearance to initiate Bria-BRES+ trial

Wed, 06 May 2026 07:30:00 -0400 - 7 days ago

BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer

Mon, 27 Apr 2026 07:30:00 -0400 - 16 days ago

BriaCell Announces Six Clinical Data Presentations at ASCO 2026

2026-04-21T13:28:43.000Z - 22 days ago

BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting

2026-04-21T11:54:23.000Z - 22 days ago

BriaCell presents anti-cancer activity of Bria-OTS

Tue, 21 Apr 2026 07:30:00 -0400 - 22 days ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models

2026-04-20T13:32:04.000Z - 23 days ago

BriaCell (BCTX) Showcases Positive Clinical Data at AACR Annual Meeting

2026-04-20T11:41:56.000Z - 23 days ago

BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR

Mon, 20 Apr 2026 07:30:00 -0400 - 23 days ago

BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

Tue, 31 Mar 2026 16:05:00 -0400 - 6 weeks ago

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

2026-03-18T13:30:56.000Z - 2 months ago

BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeting

2026-03-18T11:42:55.000Z - 2 months ago

BriaCell to present four posters at the 2026 AACR

Wed, 18 Mar 2026 07:30:00 -0400 - 2 months ago

BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference

Tue, 10 Mar 2026 07:30:00 -0400 - 2 months ago

BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting

Thu, 05 Mar 2026 16:04:00 -0500 - 2 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

2026-02-18T22:51:30.000Z - 2 months ago

BriaCell (BCTX) Expands Biologic Cancer Treatments Through New Agreement

2026-02-18T22:35:25.000Z - 2 months ago

BriaPro to purchase BriaCell’s license to develop, commercialize sCD80

Wed, 18 Feb 2026 17:30:00 -0500 - 2 months ago

BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

2026-02-17T12:40:59.000Z - 3 months ago

BriaCell receives positive recommendation from DSMB for Phase 3 Bria-ABC study

Tue, 17 Feb 2026 07:30:00 -0500 - 3 months ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

2026-01-28T13:30:56.000Z - 3 months ago

BriaCell Therapeutics (BCTX) Shows Promising Results in Metastatic Breast Cancer Treatment

2026-01-28T12:40:40.000Z - 3 months ago

BriaCell says patient images show regression, resolution of metastsized tumors

Wed, 28 Jan 2026 07:30:00 -0500 - 3 months ago

BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

2026-01-27T13:32:37.000Z - 3 months ago

BriaCell (BCTX) Reports Promising Phase 2 Survival Data

2026-01-27T12:41:04.000Z - 3 months ago

BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer

Tue, 27 Jan 2026 07:30:00 -0500 - 3 months ago

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

2026-01-19T16:00:45.000Z - 4 months ago

Is the Market Bullish or Bearish on BriaCell Therapeutics Corp?

2026-01-16T13:58:57.000Z - 4 months ago

Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch

Thu, 15 Jan 2026 16:05:00 -0500 - 4 months ago

BriaCell Therapeutics Announces Closing of US$30 million Public Offering

2026-01-14T11:36:30.000Z - 4 months ago

What's Going On With BriaCell Therapeutics Stock Wednesday?

2026-01-14T11:19:44.000Z - 4 months ago

BriaCell Plunges On Pricing Announcement Of $30Mln Public Offering

2026-01-14T10:55:53.000Z - 4 months ago

BriaCell (BCTX) Unveils $30M Public Offering, Stock Dips 9.7%

2026-01-14T06:56:44.000Z - 4 months ago

BriaCell Therapeutics (BCTX) Launches $30M Public Offering

Tue, 13 Jan 2026 21:00:00 -0500 - 4 months ago

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

2026-01-13T20:32:32.000Z - 4 months ago

BCTX Surges On Positive Clinical Response In Metastatic Cancer Immunotherapy Study

2026-01-13T14:41:11.000Z - 4 months ago

BriaCell Therapeutics trading resumes

2026-01-13T14:35:29.000Z - 4 months ago

BriaCell Therapeutics trading halted, volatility trading pause

2026-01-13T14:08:02.000Z - 4 months ago

BriaCell Surge Above 50%; What's The Buzz?

2026-01-13T12:53:09.000Z - 4 months ago

BriaCell (BCTX) Reports Impressive Lung Metastasis Resolution in Cancer Trial

2026-01-13T12:35:49.000Z - 4 months ago

BriaCell reports sustained complete resolution of lung metastasis in Bria-OTS

Tue, 13 Jan 2026 07:30:00 -0500 - 4 months ago

BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient

Thu, 18 Dec 2025 07:30:00 -0500 - 5 months ago

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

2025-12-10T13:29:00.000Z - 5 months ago

BriaCell (BCTX) Highlights Promising Data at 2025 SABCS Symposium

2025-12-10T12:41:29.000Z - 5 months ago

BriaCell presents Phase 2, Phase 3 data on Bria-IMT at SABCS 2025

Wed, 10 Dec 2025 07:30:00 -0500 - 5 months ago

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025

2025-12-09T13:34:16.000Z - 5 months ago

BriaCell (BCTX) Progresses with Phase 3 Study in Metastatic Breast Cancer

2025-12-09T12:35:35.000Z - 5 months ago

BriaCell announces Phase 3 patient enrollment on track for 1H26 data readout

Dec 9, 2025, 7:30 AM EST - 5 months ago

BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

2025-12-02T12:36:29.000Z - 5 months ago

BriaCell to present Phase 2 survival, Phase 3 data at SABCS 2025

Dec 2, 2025, 7:30 AM EST - 5 months ago

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

Nov 25, 2025, 7:30 AM EST - 6 months ago

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

2025-11-20T12:40:35.000Z - 6 months ago

BriaCell, Receptor.AI collaborate on AI small molecular cancer therapeutics

Nov 20, 2025, 7:30 AM EST - 6 months ago

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

Nov 18, 2025, 7:30 AM EST - 6 months ago

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

2025-11-07T12:41:48.000Z - 6 months ago

BriaCell presents anti-cancer activity of Bria-OTS at SITC 2025

Nov 7, 2025, 7:30 AM EST - 6 months ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

Nov 4, 2025, 7:30 AM EST - 6 months ago

BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models

2025-10-22T11:37:13.000Z - 7 months ago

BriaCell says DSMB recommends continuation of Phase 3 Bria-IMT study

2025-10-21T11:55:26.000Z - 7 months ago

BriaCell adds clinical sites in Phase 3 metastatic breast cancer study

Oct 21, 2025, 7:50 AM EDT - 7 months ago

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

Oct 21, 2025, 7:30 AM EDT - 7 months ago

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

Oct 20, 2025, 7:30 AM EDT - 7 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 13, 2025, 7:30 AM EDT - 7 months ago

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

Oct 3, 2025, 7:30 AM EDT - 7 months ago

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

Aug 26, 2025, 7:30 AM EDT - 9 months ago

BriaCell's Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal

Aug 25, 2025, 7:30 AM EDT - 9 months ago

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer

Aug 21, 2025, 12:00 PM EDT - 9 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 13, 2025, 7:30 AM EDT - 9 months ago

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

Jul 31, 2025, 7:30 AM EDT - 10 months ago

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study

Jul 30, 2025, 7:30 AM EDT - 10 months ago

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

Jul 29, 2025, 7:30 AM EDT - 10 months ago

BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

Jul 25, 2025, 7:30 AM EDT - 10 months ago

BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025

Jul 16, 2025, 4:05 PM EDT - 10 months ago

BriaCell Therapeutics Announces Closing of $15 million Public Offering

Jul 15, 2025, 3:05 PM EDT - 10 months ago

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

Jul 15, 2025, 7:30 AM EDT - 10 months ago

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

Jul 11, 2025, 7:30 AM EDT - 10 months ago

BriaCell's Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

Jul 10, 2025, 7:30 AM EDT - 10 months ago

BriaCell Reports Complete and Sustained Resolution of Brain Metastasis and Sustained Regression of Orbital Metastasis in “Eye-Bulging” Breast Cancer Patient

Jul 9, 2025, 7:30 AM EDT - 11 months ago

BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Metastatic Breast Cancer Study

Jul 8, 2025, 7:30 AM EDT - 11 months ago

BriaCell Phase 2 Survival Achievement: 52% of Patients Surpass One-Year Milestone in Metastatic Breast Cancer

Jul 2, 2025, 7:30 AM EDT - 11 months ago

BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven

Jun 24, 2025, 7:30 AM EDT - 11 months ago

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer

Jun 4, 2025, 7:30 AM EDT - 1 year ago

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26

BHWinehouse May. 13 at 7:16 PM

$BCTX

0 · Reply

MoeMaze May. 13 at 7:03 PM

$BCTX what’s the use of all these news if the stock is stuck where it is !!!

0 · Reply

MikeTechnician May. 13 at 6:35 PM

0 · Reply

MikeTechnician May. 13 at 3:03 PM

0 · Reply

MikeTechnician May. 13 at 12:41 PM

0 · Reply

SmallCapVoice May. 13 at 11:34 AM

0 · Reply

JediGreen May. 13 at 5:16 AM

$BCTX https://youtube.com/shorts/fCRak6pv6Tk?si=CL1QtykXz3-k0es6

0 · Reply

JediGreen May. 13 at 4:59 AM

$BCTX https://finance.yahoo.com/sectors/healthcare/articles/briacell-announces-six-clinical-data-113000237.html

0 · Reply

Rohtan May. 12 at 10:55 PM

$BCTX

0 · Reply

SmallCapGrowth May. 12 at 6:57 PM

$BCTX

1 · Reply

SmallCapGrowth May. 12 at 6:18 PM

$BCTX keeps building momentum in - ALERTS, HOT STOCKS & CHARTS https://investorshangout.com/post/view?id=6829089

0 · Reply

SmallCapGrowth May. 12 at 4:33 PM

$BCTX Phase 3 update: • 230+ patients enrolled in Bria-IMT trial • Strong site & patient demand • Interim results expected in 2026 Potential path toward approval in metastatic breast cancer if survival data is positive. NEWS: https://t.co/m0s9bNNz4n $ILLR $AIMN $VNRX

0 · Reply

SmallCapGrowth May. 12 at 4:06 PM

$BCTX keeps building momentum in its pivotal Phase 3 Bria-ABC study, with over 315 patients screened and more than 230 enrolled. Topline data is expected in 2026. The program remains under FDA Fast Track designation. https://t.co/m0s9bNNz4n #Biotech #CancerResearch #Healthcare

0 · Reply

SmallCapGrowth May. 12 at 3:05 PM

MOMO'S BREAKOUT BOARD : $BCTX keeps building momentum in its piv... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177595147 via @Investors_Hub

0 · Reply

SmallCapGrowth May. 12 at 2:57 PM

Enrollment momentum building $BCTX Phase 3 Bria-IMT study reaches 230+ patients, with growing interest from leading cancer centers. Interim data could be a major catalyst in 2026. NEWS: https://www.stockonhighalert.com/post/bctx-briacell-phase-3-bria-imt-study-enrollment-surpasses-230-patients #BioPharma #CancerTreatment #Innovation

0 · Reply

SmallCapGrowth May. 12 at 2:19 PM

$BCTX BriaCell reports strong momentum in its Phase 3 Bria-IMT study: 315+ patients screened 230+ enrolled FDA Fast Track status Topline data expected in 2026 as the company advances its immunotherapy for metastatic breast cancer. #Biotech #CancerResearch #Healthcare $BCT.X https://www.stockonhighalert.com/post/bctx-briacell-phase-3-bria-imt-study-enrollment-surpasses-230-patients

0 · Reply

SmallCapGrowth May. 12 at 1:54 PM

MOMO'S BREAKOUT BOARD : $BCTX BriaCell reports strong momentum i... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177595162 via @Investors_Hub

0 · Reply

SmallCapGrowth May. 12 at 1:48 PM

BriaCell Therapeutics Corp ( $BCTX ): $BCTX Phase 3 update: • 230+ patients... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177595002 via @Investors_Hub

0 · Reply

DunkenInvest May. 12 at 1:38 PM

$BCTX Good news and only 6,8k volume today. That's Pathetic 😂

1 · Reply

SmallCapGrowth May. 12 at 1:15 PM

0 · Reply

prismmarketview May. 12 at 1:02 PM

$BCTX BriaCell's Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients #BriaCelTherapeutics https://prismmarketview.com/briacell-phase-3-bria-imt-study-enrollment-surpasses-230-patients/

0 · Reply

DunkenInvest May. 12 at 12:56 PM

$BCTX I was wrong about 8$. We're not going anywhere. Maybe we can hit 4,25$ and call it a day 😭

1 · Reply

Market Cap	30.16M
Revenue (ttm)	0.00
Net Income (ttm)	-26.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	69,330
Avg Vol	179,778
Day's Range	N/A - N/A
Shares Out	7.25M
Stochastic %K	34%
Beta	1.26
Analysts	Strong Buy
Price Target	$40.00